270 related articles for article (PubMed ID: 32958120)
1. Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes.
Kim YS; Lee SY; Yoon JW; Kim D; Yu S; Kim JS; Kim JH
BMB Rep; 2020 Nov; 53(10):545-550. PubMed ID: 32958120
[TBL] [Abstract][Full Text] [Related]
2. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
Wong AO; Gurung B; Wong WS; Mak SY; Tse WW; Li CM; Lieu DK; Costa KD; Li RA; Hajjar RJ
J Mol Cell Cardiol; 2021 Apr; 153():106-110. PubMed ID: 33373642
[TBL] [Abstract][Full Text] [Related]
4. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.
Monzani A; Genoni G; Scopinaro A; Pistis G; Kozel D; Secco GG
Eur J Clin Invest; 2020 Jun; 50(6):e13258. PubMed ID: 32356580
[No Abstract] [Full Text] [Related]
5. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
Javelot H; El-Hage W; Meyer G; Becker G; Michel B; Hingray C
Br J Clin Pharmacol; 2020 Jun; 86(6):1176-1177. PubMed ID: 32350872
[No Abstract] [Full Text] [Related]
6. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
7. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
Gérard A; Romani S; Fresse A; Viard D; Parassol N; Granvuillemin A; Chouchana L; Rocher F; Drici MD;
Therapie; 2020; 75(4):371-379. PubMed ID: 32418730
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes.
Jordaan P; Dumotier B; Traebert M; Miller PE; Ghetti A; Urban L; Abi-Gerges N
Toxicol Sci; 2021 Apr; 180(2):356-368. PubMed ID: 33483756
[TBL] [Abstract][Full Text] [Related]
9. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
Hsia BC; Greige N; Quiroz JA; Khokhar AS; Daily J; Di Biase L; Ferrick KJ; Fisher JD; Krumerman A
J Interv Card Electrophysiol; 2020 Nov; 59(2):337-345. PubMed ID: 32654098
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk.
Offerhaus JA; Wilde AAM; Remme CA
Heart Rhythm; 2020 Sep; 17(9):1480-1486. PubMed ID: 32622993
[TBL] [Abstract][Full Text] [Related]
11. In vitro safety "clinical trial" of the cardiac liability of drug polytherapy.
Charrez B; Charwat V; Siemons B; Finsberg H; Miller EW; Edwards AG; Healy KE
Clin Transl Sci; 2021 May; 14(3):1155-1165. PubMed ID: 33786981
[TBL] [Abstract][Full Text] [Related]
12. Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.
Medeiros-Domingo A; Carrasco OF; Berni-Betancourt A
Arch Cardiol Mex; 2020; 90(Supl):36-40. PubMed ID: 32523150
[TBL] [Abstract][Full Text] [Related]
13. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
[TBL] [Abstract][Full Text] [Related]
14. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
Sarayani A; Cicali B; Henriksen CH; Brown JD
Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
16. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.
Borba MGS; Val FFA; Sampaio VS; Alexandre MAA; Melo GC; Brito M; Mourão MPG; Brito-Sousa JD; Baía-da-Silva D; Guerra MVF; Hajjar LA; Pinto RC; Balieiro AAS; Pacheco AGF; Santos JDO; Naveca FG; Xavier MS; Siqueira AM; Schwarzbold A; Croda J; Nogueira ML; Romero GAS; Bassat Q; Fontes CJ; Albuquerque BC; Daniel-Ribeiro CT; Monteiro WM; Lacerda MVG;
JAMA Netw Open; 2020 Apr; 3(4):e208857. PubMed ID: 32330277
[TBL] [Abstract][Full Text] [Related]
17. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
[No Abstract] [Full Text] [Related]
18. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
19. Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin.
Sutanto H; Heijman J
Front Physiol; 2020; 11():587709. PubMed ID: 33192602
[TBL] [Abstract][Full Text] [Related]
20. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
Naksuk N; Lazar S; Peeraphatdit TB
Eur Heart J Acute Cardiovasc Care; 2020 Apr; 9(3):215-221. PubMed ID: 32372695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
